COMMUNIQUÉS West-GlobeNewswire

Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed
20/03/2024
Seek approval from the FDA for the modification of the Gloperba ® label to include its ability to utilize dosing flexibility of liquid formulation to address unmet medical needs and provide specific dosing guidance to [...]
COVID Origin Is a Gordian Knot, according to the Journal of American Physicians and Surgeons
20/03/2024
TUCSON, Ariz., March 20, 2024 (GLOBE NEWSWIRE) -- Controversy over the origin of the SARS-CoV-2 virus that causes COVID-19—a natural zoonosis vs. a lab leak—has escalated to high-level acrimony and even threatened [...]
Decisions taken by Orion Corporation’s Annual General Meeting on 20 March 2024
20/03/2024
ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING 20 MARCH 2024 at 16.50 EET Decisions taken by Orion Corporation’s Annual General Meeting on 20 March 2024 At the Annual General Meeting of Orion [...]
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
20/03/2024
Novel MDMA-Like Drug Could Be Used for Numerous Neurological and Psychiatric Indications TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: [...]
XTL To Aquire The Social Proxy
20/03/2024
expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million in a Private Placement RAMAT GAN [...]
Dr. Zeke Unveils Breakthrough Scoliosis Treatment, Transforming Lives in Austin, TX
20/03/2024
AUSTIN, Texas, March 20, 2024 (GLOBE NEWSWIRE) -- Dr. Zeke Harkleroad, has specialized in the field of spinal health and scoliosis treatment for over 25 years, is making waves once again with life-changing advancements [...]
Immix Biopharma Announces Major Comprehensive Cancer Center as Lead Site for NXC-201 AL Amyloidosis Clinical Trial
20/03/2024
LOS ANGELES, CA, March 20, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us” or “IMMX”), a clinical-stage biopharmaceutical company trailblazing cell therapies in AL [...]
Nurix Presents the Discovery and Chemical Structure of First-in-Class CBL-B Inhibitor NX-1607 at the American Chemical Society (ACS) Meeting
20/03/2024
Presentation highlights Nurix’s innovation and leadership in targeted protein modulation, including ligase inhibition Unique mechanism of action, an intramolecular glue, locks the E3 ligase Casitas B-lineage lymphoma [...]
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
20/03/2024
OCALA, Fla., March 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website. For the CEO [...]
Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy
20/03/2024
Company Has Already Received IND Clearance from the FDA and Plans to Begin Phase 1/2 Study in 2024 with Off-the-Shelf, Placental-Derived Cell Therapy FLORHAM PARK, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Celularity Inc [...]
TFF Pharmaceuticals Announces Update on Clinical Programs
20/03/2024
Company to Prioritize Clinical Development of Tacrolimus Inhalation Powder (TFF TAC) based on Positive Phase 2 Data, the Potential to Address a Significant Unmet Need in Lung Transplant Medicine and Substantial Market [...]
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
20/03/2024
GARDEN CITY, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ, Sets Sights on Expansion Into Costa Rica and Central America
20/03/2024
AUSTIN, Texas, March 20, 2024 (GLOBE NEWSWIRE) -- via IBN – Eko2o S.A.S., a leader in sustainable agricultural technologies and a majority-owned subsidiary of SFWJ, doing business as MedCana, today announces its [...]
RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury
20/03/2024
Glen Rock, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the “Company”), focused on the discovery and development of innovative and revolutionary [...]
Safety Shot, Inc. (Nasdaq: SHOT) Announces Strategic Partnership with Launch 33 Brands to Expand Distribution in Los Angeles
20/03/2024
JUPITER, FL, March 20, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) proudly announces its new collaboration with Launch 33 Brands, a leading brand building agency and distributor based in Los Angeles, to [...]
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health
20/03/2024
WINNIPEG, Manitoba, March 20, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announces today that it has extended the exclusivity period on the offer for its [...]
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
20/03/2024
OXFORD, United Kingdom, March 20, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc, announced its financial results for the year ended December 31, 2023, and an overview of [...]
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
20/03/2024
-- In the severe male factor cohort, findings show 24% of women became pregnant after FemaSeed -- -- FemaSeed pregnancy rate by cycle was more than double historic intrauterine insemination (IUI) rate -- -- Of those [...]
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
20/03/2024
Live Conference Call and Webcast at 8:30 a.m. ET PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter [...]

Pages